ATE222764T1 - Hydroxyomeprazol-enthaltende zubereitungen und verwendungen - Google Patents

Hydroxyomeprazol-enthaltende zubereitungen und verwendungen

Info

Publication number
ATE222764T1
ATE222764T1 AT99922802T AT99922802T ATE222764T1 AT E222764 T1 ATE222764 T1 AT E222764T1 AT 99922802 T AT99922802 T AT 99922802T AT 99922802 T AT99922802 T AT 99922802T AT E222764 T1 ATE222764 T1 AT E222764T1
Authority
AT
Austria
Prior art keywords
hydroxyomeprazole
omeprazole
treatment
containing preparations
drug
Prior art date
Application number
AT99922802T
Other languages
German (de)
English (en)
Inventor
William E Yelle
Dean A Handley
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Application granted granted Critical
Publication of ATE222764T1 publication Critical patent/ATE222764T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT99922802T 1998-05-05 1999-05-05 Hydroxyomeprazol-enthaltende zubereitungen und verwendungen ATE222764T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8425898P 1998-05-05 1998-05-05
PCT/US1999/009814 WO1999056746A1 (en) 1998-05-05 1999-05-05 Hydroxyomeprazole compositions and uses

Publications (1)

Publication Number Publication Date
ATE222764T1 true ATE222764T1 (de) 2002-09-15

Family

ID=22183810

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99922802T ATE222764T1 (de) 1998-05-05 1999-05-05 Hydroxyomeprazol-enthaltende zubereitungen und verwendungen

Country Status (9)

Country Link
US (2) US6294586B1 (cg-RX-API-DMAC7.html)
EP (1) EP1082114B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003517434A (cg-RX-API-DMAC7.html)
AT (1) ATE222764T1 (cg-RX-API-DMAC7.html)
AU (1) AU748872B2 (cg-RX-API-DMAC7.html)
CA (1) CA2330049A1 (cg-RX-API-DMAC7.html)
DE (1) DE69902657T2 (cg-RX-API-DMAC7.html)
ES (1) ES2182524T3 (cg-RX-API-DMAC7.html)
WO (1) WO1999056746A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420435B1 (en) * 1999-11-01 2002-07-16 Joe S. Wilkins, Jr. Method for treating gastrointestinal disorders
US6987123B2 (en) * 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
US7041706B2 (en) * 2002-04-19 2006-05-09 Wilkins Jr Joe S Method for treating crohn's disease
AU2004206141A1 (en) * 2003-01-24 2004-08-05 Niva Shapira Synergistic compositions and methods for potentiating anti-oxidative activity
WO2005032554A1 (en) 2003-10-03 2005-04-14 Astron Research Pvt. Ltd A novel transmucosal delivery system
ES2281292B1 (es) * 2006-03-08 2008-06-16 Quimica Sintetica S.A. Nuevas sales de esomeprazol. procedimiento de preparacion y composiciones farmaceuticas que las comprenden.

Also Published As

Publication number Publication date
US20020010196A1 (en) 2002-01-24
EP1082114B1 (en) 2002-08-28
DE69902657T2 (de) 2003-04-30
JP2003517434A (ja) 2003-05-27
DE69902657D1 (de) 2002-10-02
US6498171B2 (en) 2002-12-24
ES2182524T3 (es) 2003-03-01
EP1082114A1 (en) 2001-03-14
CA2330049A1 (en) 1999-11-11
WO1999056746A1 (en) 1999-11-11
AU3971699A (en) 1999-11-23
AU748872B2 (en) 2002-06-13
US6294586B1 (en) 2001-09-25

Similar Documents

Publication Publication Date Title
SE0102315D0 (sv) Compounds
HUP9702035A2 (hu) Leukocitaadhéziót gátló és VLA-4-antagonista vegyületek, valamint e vegyületeket tartalmazó gyógyászati készítmények
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
NO933999L (no) Fibrinogenreseptorantagonister
NO20013770D0 (no) Metoder og blandinger for å öke antall hvite blodceller
ATE461237T1 (de) Konjugierte copolymere aus dithienothiophen und vinylen oder acetylen
DE60011515D1 (de) Herstellung von Keramiksubstraten und ungesintertes Keramiksubstrat
DE69212430D1 (de) Copolymere aus Protein und Siloxan und diese enthaltende Zusammensetzungen
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
SE0203825D0 (sv) Novel fused heterocycles and uses thereof
DE60042401D1 (de) Fab-i inhibitoren
DE60224957D1 (de) Harzzusammensetzung zur Einkapselung von Halbleitern und diese enthaltende Halbleiteranordnungen
WO2005099312A3 (en) Triarylamine compounds for use as charge transport materials
DE60209990D1 (de) Stabilisatoren als Polymerisationsinhibitoren von substituierten Cyclotetrasiloxanen
DK1098893T3 (da) Cykliske forbindelser, der kan anvendes i behandlingen af dyslipidæmi, aterosklerose og diabetes, farmaceutiske præparater og fremstillingsfremgangsmåde
ATE339968T1 (de) Verwendung von mglur5 antagonists zur herstellung von medikamenten zur behandlung von empfindlichen x syndrome, autismus und geistiger zurückgebliebenheit
NO20014314D0 (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
TR199901730T2 (xx) �ift halkal� karboksamidler ve bunlar�n terap�tik kullan�m�
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
DE69902657D1 (de) Hydroxyomeprazol-enthaltende zubereitungen und verwendungen
NO20051404L (no) Pyridylsubstituerte heterocykluser som er nyttige for behandling eller forebyggelse av HCV infeksjon
DE69710111D1 (de) Behandlung und Prophylaxe von Pankreatitis
ATE275143T1 (de) Verbindungen
TR199903308T2 (xx) 8-Kloro-6,11-dihidro-11- (4-piperidiliden)-5H-benzo $5,6]siklohepta $1,2-b]piridin polimorflar�.
DK1075262T3 (da) Desmethylpantoprazolpræparater og -fremgangsmåder

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties